Mental Health Clinics in Burlington, CT Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Catalyst Counseling Of Connecticut Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 9 Covey Rd, 2af, Burlington, CT 06013 Phone: 860-550-1490 |
Healing Dialogue Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 156 Deer Run, Burlington, CT 06013 Phone: 860-805-5830 |
Gradual Growth Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 97 Rock Rd, Burlington, CT 06013 Phone: 860-770-4194 |
Real Talk Ct, Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 258 Spielman Hwy, Burlington, CT 06013 Phone: 860-325-0579 |
Therapeutic Counseling Center Of Connecticut Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 258 Spielman Hwy, Burlington, CT 06013 Phone: 860-325-0579 |
News Archive
High cost of health care not justified
A policy paper that identifies and analyzes the key drivers of health care costs was released today by the American College of Physicians (ACP). Controlling Health Care Costs While Promoting the Best Possible Health Outcomes provides nearly four dozen recommendations to achieve better quality care to more people.
Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis
Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).
Stimulate the brain and reduce the risk of Alzheimer's!
According to a new study elderly people can reduce their risk of developing Alzheimer's disease by reading newspapers, playing chess, or engaging in other mentally stimulating activities.
Bioenergetic analysis of pancreatic beta-cells shows impaired metabolic signature in type 2 diabetes patients
Impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes. The cause of this dysfunction has been unknown. Publishing online in Endocrinology, Buck Institute assistant research professor Akos Gerencser, PhD, shows that in patients with type 2 diabetes the balance between supply and demand of the mitochondrial membrane potential (ΔψM) is altered causing a decrease in the signaling that turns on insulin secretion.
› Verified 5 days ago